Safety evaluation of ribavirin in pediatric clinical application
10.13220/j.cnki.jipr.2016.04.007
- Author:
Rui-Ling ZHAO
1
Author Information
1. Department of Pharmacy, Children’ Hospital of Shanxi
- Publication Type:Journal Article
- Keywords:
Clinical application;
Drug evaluation;
Pediatrics;
Ribavirin;
Safety
- From:
Journal of International Pharmaceutical Research
2016;43(4):615-620
- CountryChina
- Language:Chinese
-
Abstract:
Ribavirin is a kind of synthetic nuclear nucleoside antiviral drugs. It can inhibit the growth of respiratory syncytial virus, influenza virus, hepatitis a virus, adenovirus and other virus, but its mechanism is not fully clear. To understand the current situation of drug information and clinical application of ribavirin, we accessed to literature in the literature database of Wanfang med online, CNKI, yz365, CFDA, FDA, DailyMed and Chinese Marketed Drugs Database. Based on the present situation of pediatrics clinical application of our hospital and the drug information of ribavirin and clinical application in children at home and abroad, we evaluated the safety of ribavirin to promote its reasonable application and make suggestions to the standardization management of ribavirin.
